Literature DB >> 16694832

CALCIUM AND PHOSPHORUS METABOLISM IN OSTEOMALACIA. XI. THE PATHOGENETIC ROLE OF PREGNANCY AND RELATIVE IMPORTANCE OF CALCIUM AND VITAMIN D SUPPLY.

S H Liu1, H I Chu, H C Hsu, H C Chao, S H Cheu.   

Abstract

Entities:  

Year:  1941        PMID： 16694832      PMCID： PMC435056          DOI： 10.1172/JCI101219

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  3 in total

1.  CALCIUM AND PHOSPHORUS METABOLISM IN OSTEOMALACIA X. FURTHER STUDIES ON VITAMIN D ACTION: EARLY SIGNS OF DEPLETION AND EFFECT OF MINIMAL DOSES.

Authors:  H I Chu; S H Liu; T F Yu; H C Hsu; T Y Cheng; H C Chao
Journal:  J Clin Invest       Date:  1940-03       Impact factor: 14.808

2.  CALCIUM AND PHOSPHORUS METABOLISM IN OSTEOMALACIA. V. THE EFFECT OF VARYING LEVELS AND RATIOS OF CALCIUM TO PHOSPHORUS INTAKE ON THEIR SERUM LEVELS, PATHS OF EXCRETION AND BALANCES, IN THE PRESENCE OF CONTINUOUS VITAMIN D THERAPY.

Authors:  S H Liu; C C Su; S K Chou; H I Chu; C W Wang; K P Chang
Journal:  J Clin Invest       Date:  1937-07       Impact factor: 14.808

3.  CALCIUM AND PHOSPHORUS METABOLISM IN OSTEOMALACIA IX. METABOLIC BEHAVIOR OF INFANTS FED ON BREAST MILK FROM MOTHERS SHOWING VARIOUS STATES OF VITAMIN D NUTRITION.

Authors:  S H Liu; H I Chu; C C Su; T F Yu; T Y Cheng
Journal:  J Clin Invest       Date:  1940-03       Impact factor: 14.808
  3 in total
  5 in total

1.  Role of vitamins in embryonic development.

Authors:  D H WOOLLAM; J W MILLEN
Journal:  Br Med J       Date:  1956-06-02

2.  Mineral metabolism of healthy adults on white and brown bread dietaries.

Authors:  R A McCance; E M Widdowson
Journal:  J Physiol       Date:  1942-06-02       Impact factor: 5.182

3.  H.-I. Chu: pioneer clinical investigator of vitamin D deficiency and osteomalacia in China. A scientific and personal tribute.

Authors:  A M Parfitt
Journal:  Calcif Tissue Int       Date:  1985-07       Impact factor: 4.333

4.  Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.

Authors:  Kausik Umanath; Diana I Jalal; Barbara A Greco; Ebele M Umeukeje; Efrain Reisin; John Manley; Steven Zeig; Dana G Negoi; Anand N Hiremath; Samuel S Blumenthal; Mohammed Sika; Robert Niecestro; Mark J Koury; Khe-Ni Ma; Tom Greene; Julia B Lewis; Jamie P Dwyer
Journal:  J Am Soc Nephrol       Date:  2015-03-03       Impact factor: 10.121

Review 5.  Ferric citrate for the treatment of hyperphosphatemia and anemia in patients with chronic kidney disease: a meta-analysis of randomized clinical trials.

Authors:  Li Li; Xin Zheng; Jin Deng; Junlin Zhou; Jihong Ou; Tao Hong
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.